Clinical Trial Update: Personalized Long-term Human Albumin Treatment in Patients With Decompensated Cirrhosis and Ascites [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating personalized long-term human albumin treatment for patients with decompensated cirrhosis and ascites is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ascites
• Decompensated Cirrhosis

Drugs mentioned

• Human Serum Albumin (human serum albumin)

Snippet

Sponsor: Aleksander Krag | Conditions: Decompensated Cirrhosis and Ascites | Phase 3 | Status: RECRUITING